Severe worsening of myasthenic symptoms after the eculizumab discontinuation. Uzawa A, Ozawa Y, Yasuda M, Kuwabara S, et al. J Neuroimmunol 2020;349:577424.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Uzawa A, Ozawa Y, Yasuda M, Kuwabara S, et al. Severe worsening of myasthenic symptoms after the eculizumab discontinuation. J Neuroimmunol 2020;349:577424.
PMID: 33068973